Atherogenic index of plasma and risk of diabetic nephropathy in type 2 diabetes: A meta‑analysis

Atherogenic index of plasma and risk of diabetic nephropathy in type 2 diabetes: A meta‑analysis

The atherogenic index of plasma (AIP) is a lipid-based biomarker associated with cardiovascular and renal risks in individuals with type 2 diabetes mellitus (T2DM). However, its relationship with diabetic nephropathy (DN) remains inadequately defined. This meta-analysis aims to assess the associati...

Full description

Saved in:

Bibliographic Details
Main Authors:	Danyan Min, Junli Zhao, Miao Liu
Format:	Article
Language:	English
Published:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2025-08-01
Series:	Biomolecules & Biomedicine
Subjects:	Type 2 diabetes atherogenic index of plasma diabetic nephropathy proteinuria meta-analysis
Online Access:	https://www.bjbms.org/ojs/index.php/bjbms/article/view/12731
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between atherogenic index of plasma and type 2 diabetes in women with a history of gestational diabetes mellitus: a cross-sectional study
by: Yanwen Sheng, et al.
Published: (2025-08-01)

Association between atherogenic index of plasma and hypertension combined with diabetes mellitus in United States adults: an analysis of the NHANES surveys from 2011 to 2016
by: Xiuqing Chen, et al.
Published: (2025-07-01)

Association between atherogenic index of plasma and risk of type 2 diabetes mellitus and the mediating effect of BMI: a comparative analysis in Chinese and Japanese populations
by: Yuheng Liao, et al.
Published: (2025-08-01)

Commentary: The atherogenic index of plasma is associated with an increased risk of diabetes in non-obese adults: a cohort study
by: Nahui Samanta Nájera-Segura, et al.
Published: (2025-07-01)

Low Plasma Atherogenic Index Associated with Poor Prognosis in Hospitalized Patients with Acute Myocardial Infarction
by: Anggoro Budi Hartopo, et al.
Published: (2016-09-01)

Atherogenic index of plasma as an additional marker of adverse cardiovascular outcomes
by: Yu. I. Grinshtein, et al.
Published: (2022-06-01)

Association of immune-inflammation indexes with incidence and prognosis of diabetic nephropathy: a systematic review and meta-analysis
by: Yijue Wang, et al.
Published: (2025-08-01)

The Association Between the Atherogenic Index of Plasma and Cognitive Function: Evidence From the NHANES 2011–2014
by: Pingping Huang, et al.
Published: (2025-08-01)

Perirenal adipose tissue accumulation mediates the adverse impact of the atherogenic index of plasma on lower extremity peripheral arterial disease
by: Xiu Li Guo, et al.
Published: (2025-07-01)

Efficacy and safety of rituximab for membranous nephropathy in adults: a meta-analysis of RCT
by: Baike Mao, et al.
Published: (2025-04-01)

Metabolic profiling in type 2 diabetes: a gender-based approach in a resource-constrained Nigerian setting
by: Oluwabukola Ayodele Ala, et al.
Published: (2025-12-01)

Association between cardiometabolic phenotypes with atherogenic index of plasma: a cross-sectional study from the Azar cohort population
by: Shirin Soheilifard, et al.
Published: (2025-08-01)

The association between atherogenic index of plasma and cognitive impairment among older adults in Southern Iran: findings from the Bushehr elderly health program
by: Mohammad Hossein Eslami, et al.
Published: (2025-08-01)

The non-linear relationship between atherogenic index of plasma and stroke: a study among middle-aged and elderly Chinese adults with depression
by: Lu Chen, et al.
Published: (2025-07-01)

An Overview of Diabetic Nephropathy
by: Alp Atasoy, et al.
Published: (2015-03-01)

Sex-specific association between atherogenic index of plasma and risk of newly diagnosed abdominal aortic aneurysm: a large population-based cohort study
by: Peng Qiu, et al.
Published: (2025-05-01)

Association of Atherogenic Index of Plasma With Stroke Risk in a Population With Cardiovascular‐Kidney‐Metabolic Syndrome Stages 0 to 3: The First Evidence From the China Health and Retirement Longitudinal Study
by: Zhanao Liu, et al.
Published: (2025-07-01)

The Correlation Between Impaired Thyroid Hormone Sensitivity and Diabetic Nephropathy in Euthyroid Patients with Type 2 Diabetes Mellitus
by: Ma D, et al.
Published: (2025-04-01)

Exploring the Incidence and Risk Factors of Diabetic Nephropathy in Type 1 Diabetes: Insights from a Retrospective Cohort Study in Northwest China
by: Du Z, et al.
Published: (2025-07-01)

Risk factors of diabetic nephropathy with retinopathy
by: Liang Dong-rui, et al.
Published: (2022-05-01)

Development and validation of a predictive nomogram for differentiating diabetic nephropathy from non-diabetic nephropathy in patients with T2DM: a multicenter study
by: Zishan Lin, et al.
Published: (2025-06-01)

The essential role of electron microscopy in the diagnosis of collagen type III glomerulopathy superimposed with membranous nephropathy or diabetic nephropathy
by: Fangcheng Zhang, et al.
Published: (2025-07-01)

Association between the atherogenic index of plasma and risk of large-artery atherosclerotic ischemic stroke
by: Wen Zhong, et al.
Published: (2025-08-01)

Analysis of diabetic nephropathy in type 2 diabetes mellitus and prediabetes
by: T. A. Garkusha, et al.
Published: (2024-01-01)

The care of the elderly with diabetic nephropathy in conservative treatment
by: Caren da Silva Jacobi, et al.
Published: (2013-08-01)

Be Alert to Diabetes Nephropathy with Cognitive Dysfunction [Letter]
by: Gan L, et al.
Published: (2024-11-01)

Research progress on biomarkers of progression of diabetic nephropathy
by: WANG Zi-yi, et al.
Published: (2020-01-01)

Exploring the role of the atherogenic index of plasma as a mediator between body roundness Index and cardiovascular events in older adults: a NHANES-based study
by: Kangming Li, et al.
Published: (2025-05-01)

Long-term analysis of сanagliflozin budget impact in adult patients with type 2 diabetes mellitus and diabetic nephropathy in the Russian Federation
by: N. A. Avxentyev, et al.
Published: (2022-10-01)

Relevance of Polymorphism of Glutathione S-Transferase Genes (GSTM1 and GSTT1) in Diabetic Retinopathy and Diabetic Nephropathy
by: Vaishali S. Pawar, et al.
Published: (2025-03-01)

Atherogenic index of plasma combined with carotid crouse score predicts coronary artery disease in young and middle-aged adults
by: Xi Wu, et al.
Published: (2025-08-01)

Association of the atherogenic index of plasma and high-sensitivity C-reactive protein with incident cardiovascular disease: evidence from a national cohort of middle-aged and older Chinese adults
by: Ping-an Lian, et al.
Published: (2025-08-01)

Association between high-sensitivity C-reactive protein and diabetic nephropathy: a systematic review and meta-analysis
by: Fattaneh Bassami, et al.
Published: (2025-07-01)

Association of polymorphisms of ACE and AT1R gene with type 2 diabetic nephropathy
by: CHENG Jie, et al.
Published: (2016-01-01)

Diagnostic value of combined detection of five biochemical indexes in early diabetic nephropathy
by: TANG Wei
Published: (2017-01-01)

Association between serum tumor markers and diabetic nephropathy in type 2 diabetes patients: a cross-sectional survey in Western China
by: Li Tao, et al.
Published: (2025-07-01)

Advances in application of ultrasound in diagnosis of diabetic nephropathy
by: GUO Juan, YANG Zhifang, JI Ri
Published: (2025-06-01)

Interrelation of the maintenance endotehelin 1-21 in serum of blood and indicators of daily monitoring of arterial pressure with diabetic nephropathy in children and the teenagers of diabetes mellitus type 1
by: A. V. Enert, et al.
Published: (2010-02-01)

The role of coagulation and inflammation in the development of diabetic nephropathy in patients withdiabetes mellitus type 2
by: Yulia Valer'evna Khasanova, et al.
Published: (2012-03-01)

Clinicopathologic classification of diabetic nephropathy and expression of Ang-2 in renal tissues
by: WEIZhi-min, et al.
Published: (2016-01-01)